Skip to content
University of Colorado DenverCU DenverUniversity of Colorado Anschutz Medical CampusCU Anschutz
  • Webmail
  • UCD Access
  • Canvas
  • Quick Links
 
 

Tools & Resources

  • Campus Directory
  • A-Z Index
  • Human Resources
  • University Policies
  • Auraria Library
  • Strauss Health Sciences Library

Schools & Colleges

CU Denver

  • College of Architecture and Planning
  • College of Arts & Media
  • Business School
  • School of Education & Human Development
  • College of Engineering, Design and Computing
  • College of Liberal Arts and Sciences
  • School of Public Affairs

CU Anschutz Medical Campus

  • School of Dental Medicine
  • Graduate School
  • School of Medicine
  • College of Nursing
  • Skaggs School of Pharmacy and Pharmaceutical Sciences
  • Colorado School of Public Health

CU Campuses

  • CU Anschutz Medical Campus
  • CU Boulder
  • CU Colorado Springs
  • CU Denver
  • CU Online
  • CU System

SPARK | REACH Colorado

  • Home
  • SPARK Awards
    • What We Fund
    • Application Process
    • Our Funding Sources
    • FAQs
    • Submit an Application
  • Who We Are
    • SPARK Fellows
    • External Review Board
    • SPARK Team
  • Events
    • SPARK Upcoming Events
    • SPARK Past Events
  • Get Involved
  • Resources
    • SPARK Documents
    • Applicant Support: Bootcamp Sessions
  • Contact Us
University Quick Links

Meet our SPARK Fellows

Pantcheva Photo_500

Mina Pantcheva, MD

Email Address:MINA.PANTCHEVA@CUANSCHUTZ.EDU

  • Bio

Gene Therapy for Glaucoma

This project is dedicated to addressing the critical requirement for novel therapeutic solutions aimed at preventing the degeneration of retinal ganglion cells (RGCs) and safeguarding vision in individuals with glaucoma, a leading cause of blindness globally. Current IOP-lowering therapies have limitations, and about 10% of patients do not respond to them. The researchers propose an innovative approach utilizing adeno-associated virus serotype 2 (AAV-2) for targeted delivery of small heat shock proteins (sHSPs) specifically to RGCs, as sHSPs have anti-apoptotic, antioxidant, and anti-inflammatory properties. 

The core objective is to explore the potential of AAV-2-mediated expression of sHSPs in shielding RGCs within animal models of glaucoma. This investigation is undertaken with the ultimate objective of developing a novel therapeutic strategy to combat this vision-threatening disease. Collaborators: Ram Nagaraj, PhD and Mi-Hyun Nam, PhD

Learn more about Dr. Pantcheva

CU Innovations

CU Anschutz

Anschutz Health Sciences Building

1890 N Revere Ct

Suite 6202

Mail Stop F411

Aurora, CO 80045


303-724-6653

Facebook Twitter LinkedIn
Additional Resources
  • CU Innovations
  • SPARK@Stanford
  • Other Funding Opportunities
  • Startup Toolbox
  • Contact Us
  • Website Feedback
  • CU System
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Accreditation
  • Employment
  • Give Now
 

© 2023 The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.

CMS Login

Webmail

UCD Access

Canvas

Opens in a new window Opens document in a new window